99.7% HPLC · SRT-6133-RET
Metabolic & WeightResearch Use Only

Retatrutide

Triple-agonist (GIP / GLP-1 / glucagon) — the newest and most-discussed metabolic-research compound.

Description references published research only; final wording pending legal review.

Strength$69
Purity
99.7%
Verified
3rd-party
Ships
< 24h
Batch verified

Per-batch lab report

The exact vial you receive is tested. Scan the QR on the label — or the code here — to open this batch's independent third-party analysis.

Batch
SRT-6133-RET
HPLC purity
99.7%
Tested by
Colorado Peptide Labs
Tested on
Feb 12, 2026
HPLCMass Spec (LC-MS)Endotoxin (LAL)
Scan to verify
View full report & chromatogram

Available strengths

5mgRT5$69
10mgRT10$99
20mgRT20$159
50mgRT50$279

Handling & storage

  • Lyophilized powder — store sealed, cool & dark before reconstitution.
  • Reconstitute with bacteriostatic water (available as an add-on).
  • Refrigerate after reconstitution; use within research window.
  • Handle under appropriate laboratory conditions only.
For Research Use Only. Retatrutide is supplied strictly for in-vitro laboratory research. It is not a drug, supplement, or food, and is not intended for human or veterinary use, consumption, or any diagnostic or therapeutic application.

More in Metabolic & Weight

GLP-1

Semaglutide

The reference GLP-1 receptor agonist — appetite, glucose-metabolism, and weight-regulation research.

98.4% HPLC
from $70–$130
GIP/GLP-1

Tirzepatide

Dual GIP / GLP-1 agonist — a stronger metabolic-research signal than single-pathway analogs.

99.9% HPLC
from $65–$195

Cagrilintide

Long-acting amylin analog — satiety and appetite-regulation research; frequently paired with semaglutide.

99.1% HPLC
from $150–$220

Cagrilintide + Semaglutide

The 'CagriSema' combination — stacked amylin + GLP-1 metabolic research in one vial.

99% HPLC
from $135–$205